Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Metrics to compare | 069620 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship069620PeersSector | |
---|---|---|---|---|
P/E Ratio | 18.0x | 8.5x | −0.6x | |
PEG Ratio | 0.25 | 0.03 | 0.00 | |
Price/Book | 2.1x | 1.1x | 2.6x | |
Price / LTM Sales | 1.2x | 0.6x | 3.1x | |
Upside (Analyst Target) | 12.6% | 26.8% | 56.8% | |
Fair Value Upside | Unlock | 20.0% | 7.7% | Unlock |